Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10754)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 21, 2019 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sookoian S, Pirola CJ. Repurposing drugs to target nonalcoholic steatohepatitis. World J Gastroenterol 2019; 25(15): 1783-1796 [PMID: 31057294 DOI: 10.3748/wjg.v25.i15.1783] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i15/1783.htm |
| Number | Citing Articles |
| 1 |
Marta Iruarrizaga-Lejarreta, Enara Arretxe, Cristina Alonso. Using metabolomics to develop precision medicine strategies to treat nonalcoholic steatohepatitis. Expert Review of Precision Medicine and Drug Development 2019; 4(5): 283 doi: 10.1080/23808993.2019.1685379
|
| 2 |
Carlos J. Pirola, Silvia Sookoian. The lipidome in nonalcoholic fatty liver disease: actionable targets. Journal of Lipid Research 2021; 62: 100073 doi: 10.1016/j.jlr.2021.100073
|
| 3 |
Ga-Ram Yu, Seung-Jun Lee, Dong-Woo Lim, Hyuck Kim, Jai-Eun Kim, Won-Hwan Park. Drug Repurposing in Alternative Medicine: Sochehwan, a Polyherbal Traditional Korean Digestant, Protects against Alcoholic Steatohepatitis by Regulating Cytochrome P450 2E1 Expression. Processes 2021; 9(10): 1760 doi: 10.3390/pr9101760
|
| 4 |
Danae Stella Zareifi, Odysseas Chaliotis, Nafsika Chala, Nikos Meimetis, Maria Sofotasiou, Konstantinos Zeakis, Eirini Pantiora, Antonis Vezakis, George K. Matsopoulos, Georgios Fragulidis, Leonidas G. Alexopoulos. A network-based computational and experimental framework for repurposing compounds toward the treatment of non-alcoholic fatty liver disease. iScience 2022; 25(3): 103890 doi: 10.1016/j.isci.2022.103890
|
| 5 |
Silvia Sookoian, Carlos J. Pirola. Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response. Clinical and Molecular Hepatology 2023; 29(Suppl): S184 doi: 10.3350/cmh.2022.0318
|
| 6 |
Castillo Tomas Augusto, María de la Paz Scribano Parada, Micaela Milagros Rossi, Franco Signorini, Ismael Fonseca, María del Carmen Baez. Pharmacological Action of Atorvastatin and Metformin on Non-alcoholic
Fatty Liver Disease on an Experimental Model of Metabolic Syndrome. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2021; 21(3): 194 doi: 10.2174/1871523022666230223090714
|
| 7 |
Cyriac Abby Philips, Guruprasad Padsalgi, Rizwan Ahamed, Rajaguru Paramaguru, Sasidharan Rajesh, Tom George, Pushpa Mahadevan, Philip Augustine. Repurposing Pirfenidone for Nonalcoholic Steatohepatitis-related Cirrhosis: A Case Series. Journal of Clinical and Translational Hepatology 2020; 8(X): 1 doi: 10.14218/JCTH.2019.00056
|
| 8 |
Silvia Sookoian, Carlos J. Pirola. Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology. Clinical and Molecular Hepatology 2020; 26(4): 461 doi: 10.3350/cmh.2020.0136
|
| 9 |
Wan-Yu Yang, Pei-Shu Rao, Yong-Chun Luo, Hua-Kuo Lin, Sing-Han Huang, Jinn-Moon Yang, Chiou-Hwa Yuh. Omics-based Investigation of Diet-induced Obesity Synergized with HBx, Src, and p53 Mutation Accelerating Hepatocarcinogenesis in Zebrafish Model. Cancers 2019; 11(12): 1899 doi: 10.3390/cancers11121899
|
| 10 |
Hua Zhang, Yongyuan Ma, Xinying Cheng, Dongbo Wu, Xingming Huang, Bin Chen, Yafeng Ren, Wei Jiang, Xiaoqiang Tang, Ting Bai, Yutian Chen, Yilin Zhao, Chunxue Zhang, Xia Xiao, Jing Liu, Yue Deng, Tinghong Ye, Lu Chen, Han-Min Liu, Scott L. Friedman, Liping Chen, Bi-Sen Ding, Zhongwei Cao. Targeting epigenetically maladapted vascular niche alleviates liver fibrosis in nonalcoholic steatohepatitis. Science Translational Medicine 2021; 13(614) doi: 10.1126/scitranslmed.abd1206
|
| 11 |
Alessandro Federico, Marcello Dallio, Mario Masarone, Antonietta Gerarda Gravina, Rosa Di Sarno, Concetta Tuccillo, Valentina Cossiga, Stefania Lama, Paola Stiuso, Filomena Morisco, Marcello Persico, Carmelina Loguercio. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients. Oxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/8742075
|
| 12 |
Ricardo Amorim, Pedro Soares, Daniel Chavarria, Sofia Benfeito, Fernando Cagide, José Teixeira, Paulo J. Oliveira, Fernanda Borges. Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities. European Journal of Medicinal Chemistry 2024; 277: 116723 doi: 10.1016/j.ejmech.2024.116723
|
| 13 |
Manush Saydmohammed, Anupma Jha, Vineet Mahajan, Dillon Gavlock, Tong Ying Shun, Richard DeBiasio, Daniel Lefever, Xiang Li, Celeste Reese, Erin E Kershaw, Vijay Yechoor, Jaideep Behari, Alejandro Soto-Gutierrez, Larry Vernetti, Andrew Stern, Albert Gough, Mark T Miedel, D Lansing Taylor. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. Experimental Biology and Medicine 2021; 246(22): 2420 doi: 10.1177/15353702211009228
|
| 14 |
Nasim Bakhtiyari, Sepideh Parvizpour, Yosef Masoudi-Sobhanzadeh, Ali Masoudi-Nejad. Computational-based strategies to deal with liver injuries induced by the repurposed drugs against SARS-CoV-2. Informatics in Medicine Unlocked 2023; 41: 101336 doi: 10.1016/j.imu.2023.101336
|
| 15 |
Paolo Caraceni, Juan G. Abraldes, Pere Ginès, Phil N. Newsome, Shiv K. Sarin. The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery. Journal of Hepatology 2021; 75: S118 doi: 10.1016/j.jhep.2021.01.024
|
| 16 |
Carlos J. Pirola, Silvia Sookoian. Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait. Clinical and Molecular Hepatology 2022; 28(4): 806 doi: 10.3350/cmh.2022.0208
|